Atlas Trials

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

Clinical trial NCT02256982 · TERMINATED

Trial details

NCT number
NCT02256982
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Unresectable Intrahepatic CholangiocarcinomaResectable Intrahepatic Cholangiocarcinoma
Start date
2014-10-01
Primary completion
2016-03-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.